Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewAprepitant is a potent long-acting hNK-1 antagonist (IC50 = 0.09 nM and Kd = 19 pM) that inhibits the effect of substance P on NK-1 receptors. Inhibits metastasis and impairs tumor growth in patient derived xenografts and breast cancer cells. In an animal model of intracerebral hemorrhage, Aprepitant reduces neurological impairment, neuronal damage and neuronal death. Suppresses pain and inflammation induced by formalin. Inhibits induced foot-tapping in gerbils. CNS penetrant and orally bioavailable. Antiemetic.
Aprepitant is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.
M. Wt | 534.43 |
Formula | C23H21F7N4O3 |
Storage | Store at -20°C |
Purity | ≥99% (HPLC) |
CAS Number | 170729-80-3 |
PubChem ID | 6918365 |
InChI Key | ATALOFNDEOCMKK-OITMNORJSA-N |
Smiles | C[C@H](C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)O[C@H]2OCCN([C@H]2C3=CC=C(C=C3)F)CC4=NNC(N4)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 53.44 | 100 | |
ethanol | 5.34 | 10 |
The following data is based on the product molecular weight 534.43. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.87 mL | 9.36 mL | 18.71 mL |
5 mM | 0.37 mL | 1.87 mL | 3.74 mL |
10 mM | 0.19 mL | 0.94 mL | 1.87 mL |
50 mM | 0.04 mL | 0.19 mL | 0.37 mL |
References are publications that support the biological activity of the product.
Hale et al (1998) Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 recepto J.Med.Chem. 41 4607 PMID: 9804700
Jin et al (2022) Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCd pathway in a mouse model of intracerebral hemorrhage. J.Neuroinflammation 19 198 PMID: 35922848
Padmanaban et al (2024) Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature 633 207 PMID: 39112700
Yang et al (2022) Aprepitant inhibits JNK and p38/MAPK to attenuate inflammation and suppresses inflammatory pain. Front.Pharmacol. 12 811584 PMID: 35087409
If you know of a relevant reference for Aprepitant, please let us know.
Keywords: Aprepitant, Aprepitant supplier, human, substance, P/neurokinin, 1, NK1, hNK1, antagonists, antagonism, tachykinin, receptors, P, SP, antiemetics, CNS, penetrant, orally, bioavailable, Receptor, 6486, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Aprepitant include:
Veronica A et al (2022) Dopamine D2 receptors bidirectionally regulate striatal enkephalin expression: Implications for cocaine reward. Cell Rep 40 111440 PMID: 36170833
Do you know of a great paper that uses Aprepitant from Tocris? Please let us know.
Average Rating: 5 (Based on 1 Review.)
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
In vivo, solution formulation
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.